Find a Clinical Trial
Filter
HER2 Negative Breast Cancer
Breast cancer
All genders
18+
Recruiting now
Department of Medicine, Division of Hematology/Oncology, Cancer Center
Mirvetuximab Soravtansine With Bevacizumab Versus Bevacizumab as Maintenance in Platinum-sensitive Ovarian, Fallopian Tube, or Peritoneal Cancer (GLORIOSA)
Fallopian tube cancer, Ovarian cancer, Peritoneal cancer
All genders
18+
Recruiting now
Cancer Center
Pembrolizumab vs. Observation in People With Triple-negative Breast Cancer Who Had a Pathologic Complete Response After Chemotherapy Plus Pembrolizumab
Breast cancer
All genders
18+
Recruiting now
Department of Medicine, Division of Hematology/Oncology, Cancer Center
NRG-BN009
Brain cancer
All genders
18+
Recruiting now
Department of Medicine, Division of Hematology/Oncology, Cancer Center
BCL Study
Breast cancer
Female
18+
Recruiting now
Department of Surgery